Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged
Untitled
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Haematologica, Volume 107, Issue 6 by Haematologica - Issuu
PDF) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
Haematologica, Volume 106, Issue 11 by Haematologica - Issuu
Cancers | Free Full-Text | Chromosomal Instability in Acute Myeloid Leukemia
Vol. 102 No. 8 (2017): August, 2017 | Haematologica
PDF) Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia
Haematologica, Volume 104, Issue 10 by Haematologica - Issuu
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
IJMS | Free Full-Text | Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
Haematologica, Volume 106, Issue 1 by Haematologica - Issuu
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease | Haematologica
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Haematologica, Volume 105, issue 2 by Haematologica - Issuu
Haematologica, Volume 102, issue 10 by Haematologica - Issuu
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment | Blood Cancer Journal
PDF) Use of the HLA-B leader to optimize cord-blood transplantation
Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Media
Cancers | Free Full-Text | Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality
